Selective Motor Neuron Death in ALS

NOMIS is funding a multi-year research project entitled Genetic Engineering of Induced Pluripotent Stem Cells and Reprogramming of Motor Neurons to Elucidate Selective Motor Neuron Death in ALS (Amyotrophic Lateral Sclerosis). ALS is a progressive neurodegenerative disease affecting nerve cells in the brain and spinal cord, whose root cause is still unknown and for which only the most limited treatment is available. This important research project has the potential to aid in the development of targeted therapies and more effective treatment options for this devastating disease.

The project is being led by Prof. Oliver Mühlemann und Dr. Marc- David Ruepp at the University Bern.